Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05595837 · ClinicalTrials.gov registry record
Immune Registry for Organ Transplantation From COVID Positive Donors.
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 20
- Enrollment target
NCT05595837: Completed study, sponsored by Virginia Commonwealth University.
NCT05595837 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05595837 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data generated by standard clinical practice to determine the short term and long term clinical outcomes of recipients of solid organ transplantation from COVID-19 infected donors and compare it to recipients with organ transplant from COVID-19 negative donors.
Interventions
- OTHER Standard organ transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-12-29 |
| Est. Completion | 2025-07-20 |
What the finished NCT05595837 record still lists
NCT05595837 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Standard organ transplant is the first listed.
NCT05595837 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05595837 about?
NCT05595837 is a clinical study titled "Immune Registry for Organ Transplantation From COVID Positive Donors.". The purpose of this study is to collect data generated by standard clinical practice to determine the short term and long term clinical outcomes of recipients of solid organ transplantation from COVID-19 infected donors and compare it to recipients with organ transplant from COVID-19 negative donors...
What is the current status of trial NCT05595837?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-12-29. Estimated completion is 2025-07-20.
What interventions are being tested in trial NCT05595837?
The interventions under investigation include: Standard organ transplant (OTHER).
Who is sponsoring clinical trial NCT05595837?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI